SynthesisBritish journal of clinical pharmacology2022

Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis.

Jonathan Mauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.